Signs of inflammatory bowel disease (IBD) activity, shorter duration of IBD, and previous corticosteroid use and hospitalisation were associated with Clostridioides difficile infection in patients ...

A recurrence of C. diff is common after an initial episode, with about 20% of people having a recurrence. A recurrence is ...

The study of Clostridium difficile infection (CDI) continues to reveal intricate details of its pathogenesis, epidemiology and potential novel therapies. Research has elucidated how the bacterium, ...

FMT restores gut microbiota balance by transferring stool from healthy donors, mainly for recurrent C. difficile infections. Recent data shows FMT's high efficacy in preventing recurrent C. difficile, ...

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides ...

A team of biochemists at the University of Notre Dame has found a possible new way to treat patients infected with Clostridioides difficile, a type of bacteria that causes serious gastrointestinal ...

The panelist discusses how recurrent Clostridioides difficile infections involve complex differential diagnosis, including persistent infection, reinfection, and other gastrointestinal conditions.

Antibiotic use in the outpatient setting is a significant risk factor for contracting Clostridium difficile outside of a healthcare environment, according to a study published in the journal Open ...

Novel C. diff vaccine shows long-term protection in animal studies, reducing illness, death, and infection recurrence, per Vanderbilt Health research.

Dentists wrote more than 2.3 million prescriptions last year for an antibiotic called clindamycin, whose label has carried a ...

An infection with Clostridioides difficile (or C. diff in the trade) that occurs 72 hours after admission to the hospital is considered hospital-acquired. Medicare penalizes hospitals financially if ...